Prakiraan wutah bathi resik saben saham kanggo taun ngarep ImmunityBio (IBRX)
Expectations for ImmunityBio, Inc. (IBRX) EPS growth next year rely on the powerful technological foundation of the company's US laboratories. However, 69.10 becomes the new value for this metric amid high capital burn and FDA regulatory risks. The business is currently focusing on establishing a distribution network for its first drug, completely ruling out merger deals with other players.
Rincian metrik lan analitis perusahaan immunitybio.com (IBRX)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas ImmunityBio, Inc.|IBRX - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas ImmunityBio|IBRX - Tanggungan utang total perusahaan|Utang marang nilai buku ImmunityBio|IBRX - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan ImmunityBio|Rasio cepet immunitybio.com
- statistik bathi lan rasio pasar:
IBRX - Penghasilan resik perusahaan|Bathi sing dikarepake ImmunityBio, Inc.|IBRX - Nilai perusahaan marang bathi resik|Pangali Forward P/E ImmunityBio, Inc.|IBRX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ImmunityBio|IBRX - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan ImmunityBio|IBRX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan immunitybio.com|IBRX - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ImmunityBio, Inc.
Analisis kabeh metrik perusahaan:ImmunityBio Corp
This indicator reflects the daily aggregation of expert expectations regarding net profit growth rates, allowing for a correlation between the current share price of ImmunityBio, Inc. (IBRX) and its future returns. By analyzing the consensus for next year's earnings per share (EPS) changes, investors can see the impact of the commercialization of the unique IL-15 therapy and patent protection, which confirms the fundamental resilience of the business in the face of competitors.
Pesaing langsung
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Immunocore PLC|Prakiraan wutah bathi saben saham kanggo taun ngarep Janux Corp (JANX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Arcus Biosciences, Inc. (RCUS)|Prakiraan wutah bathi saben saham kanggo taun ngarep zymeworks.com ZYME|Tango Therapeutics, Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Iovance Biotherapeutics Inc IOVA|IMTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|XNCR (Xencor Inc.) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Compass Therapeutics (CMPX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep replimune.com (REPL)|Prakiraan wutah bathi saben saham kanggo taun ngarep LYEL|IPHA - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep PYXS (Pyxis Oncology, Inc.)|Proyeksi tambahing bathi saben saham ing taun ngarep CGEN|Prakiraan wutah bathi kanggo taun ngarep IOBT (IO Biotech, Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep STRO|MiNK Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Werewolf Therapeutics|immixbio.com (IMMX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|ALX Oncology Holdings Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|CUE (Cue Biopharma, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PDS Biotechnology Corp|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Sonnet BioTherapeutics (SONN)|MAIA: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Liminatus Pharma Corp - Prakiraan wutah bathi saben saham kanggo taun ngarep|LAVA Therapeutics NV (LVTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|NextCure, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Leap Therapeutics, Inc. LPTX|intensitytherapeutics.com (INTS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Sensei Biotherapeutics, Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Synthetic Biologics|Prakiraan wutah bathi saben saham kanggo taun ngarep Gritstone Bio (GRTS)|Prakiraan wutah bathi saben saham kanggo taun ngarep KA (Kineta, Inc.)|Prakiraan wutah bathi kanggo taun ngarep neximmune.com (NEXI)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Turnstone Biologics Corp. TSBX|VCNX: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Harpoon Tx - Prakiraan wutah bathi kanggo taun ngarep
